Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paul Ridker
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Concepts & Ideas
Disorders
Procedures
Physiology
Geographic Areas
Sign-in to see full Profile
Network (preview)
90
Buring, Julie
77
Rifai, Nader
57
Zee, Robert
53
Hennekens, Charles
51
Manson, JoAnn
43
Cook, Nancy
36
Stampfer, Meir
27
Glynn, Robert
18
Chasman, Daniel
15
Pradhan, Aruna
14
Gaziano, Michael
13
Lindpaintner, Klaus
12
Libby, Peter
12
Albert, Michelle
11
Goldhaber, Samuel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paul Ridker (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Rajpathak Swapnil N; Kumbhani Dharam J; Crandall Jill; Barzilai Nir; Alderman Michael; Ridker Paul M
Statin therapy and risk of developing type 2 diabetes: a meta-analysis.
Diabetes care 2009;32(10):1924-9.
-
2009: Pradhan Aruna D; Everett Brendan M; Cook Nancy R; Rifai Nader; Ridker Paul M
Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial.
JAMA : the journal of the American Medical Association 2009;302(11):1186-94.
-
2009: Conen David; Rexrode Kathryn M; Creager Mark A; Ridker Paul M; Pradhan Aruna D
Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study.
Circulation 2009;120(12):1041-7.
-
2009: Romero José R; Ridker Paul M; Zee Robert Y L
Gene variation of the transient receptor potential cation channel, subfamily M, member 7 (TRPM7), and risk of incident ischemic stroke: prospective, nested, case-control study.
Stroke; a journal of cerebral circulation 2009;40(9):2965-8.
-
2009: Goulart Alessandra C; Rexrode Kathryn M; Cheng Suzanne; Rose Lynda; Buring Julie E; Ridker Paul M; Zee Robert Y L
Association of genetic variants with the metabolic syndrome in 20,806 white women: The Women's Health Genome Study.
American heart journal 2009;158(2):257-262.e1.
-
2009: Zee Robert Y L; Michaud Sherri E; Ridker Paul M
Mean telomere length and risk of incident venous thromboembolism: a prospective, nested case-control approach.
Clinica chimica acta; international journal of clinical chemistry 2009;406(1-2):148-50.
-
2009: Ridker Paul M
Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).
Journal of thrombosis and haemostasis : JTH 2009;7 Suppl 1():332-9.
-
2009: Friedewald Vincent E; Kornman Kenneth S; Beck James D; Genco Robert; Goldfine Allison; Libby Peter; Offenbacher Steven; Ridker Paul M; Van Dyke Thomas E; Roberts William C;
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease.
The American journal of cardiology 2009;104(1):59-68.
-
2009: Friedewald Vincent E; Kornman Kenneth S; Beck James D; Genco Robert; Goldfine Allison; Libby Peter; Offenbacher Steven; Ridker Paul M; Van Dyke Thomas E; Roberts William C;
The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease.
Journal of periodontology 2009;80(7):1021-32.
-
2009: Ridker Paul M
Moving toward new statin guidelines in a post-JUPITER world: principles to consider.
Current atherosclerosis reports 2009;11(4):249-56.
-
2009: Cook Nancy R; Ridker Paul M
Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures.
Annals of internal medicine 2009;150(11):795-802.
-
2009: Conen David; Glynn Robert J; Ridker Paul M; Buring Julie E; Albert Michelle A
Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals.
European heart journal 2009;30(11):1378-84.
-
2009: Arant Christopher B; Wessel Timothy R; Ridker Paul M; Olson Marian B; Reis Steven E; Delia Johnson B; Sharaf Barry L; Pauly Daniel F; Handberg Eileen; Zineh Issam; Sopko George; Kelsey Sheryl F; Noel Bairey Merz C; Pepine Carl J
Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the national heart, lung, and blood institute-sponsored women's ischemia syndrome evaluation.
Clinical cardiology 2009;32(5):244-50.
-
2009: Ridker Paul M; Friedewald Vincent E; Davidson Michael H; Willerson James T; Roberts William C
The editor's roundtable: the JUPITER trial--initial results and clinical implications.
The American journal of cardiology 2009;103(10):1417-25.
-
2009: Ridker Paul M; Solomon Daniel H
Should patients with rheumatoid arthritis receive statin therapy?
Arthritis and rheumatism 2009;60(5):1205-9.
-
2009: Mora Samia; Rifai Nader; Buring Julie E; Ridker Paul M
Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
Clinical chemistry 2009;55(5):888-94.
-
2009: Paynter Nina P; Cook Nancy R; Everett Brendan M; Sesso Howard D; Buring Julie E; Ridker Paul M
Prediction of incident hypertension risk in women with currently normal blood pressure.
The American journal of medicine 2009;122(5):464-71.
-
2009: Zee Robert Y L; Michaud Sherri E; Germer Soren; Ridker Paul M
Association of shorter mean telomere length with risk of incident myocardial infarction: a prospective, nested case-control approach.
Clinica chimica acta; international journal of clinical chemistry 2009;403(1-2):139-41.
-
2009: Albert Michelle A; Pare Guillaume; Morris Alanna; Rose Lynda; Buring Julie; Ridker Paul M; Zee Robert Y L
Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study.
American heart journal 2009;157(4):777-83.e1.
-
2009: Glynn Robert J; Danielson Eleanor; Fonseca Francisco A H; Genest Jacques; Gotto Antonio M; Kastelein John J P; Koenig Wolfgang; Libby Peter; Lorenzatti Alberto J; MacFadyen Jean G; Nordestgaard Børge G; Shepherd James; Willerson James T; Ridker Paul M
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.
The New England journal of medicine 2009;360(18):1851-61.
-
2009: Ridker Paul M; Danielson Eleanor; Fonseca Francisco Ah; Genest Jacques; Gotto Antonio M; Kastelein John Jp; Koenig Wolfgang; Libby Peter; Lorenzatti Alberto J; Macfadyen Jean G; Nordestgaard Børge G; Shepherd James; Willerson James T; Glynn Robert J;
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Lancet 2009;373(9670):1175-82.
-
2009: Zee Robert Y L; Bubes Vadim; Shrivastava Sanjay; Ridker Paul M; Glynn Robert J
Genetic risk factors in recurrent venous thromboembolism: A multilocus, population-based, prospective approach.
Clinica chimica acta; international journal of clinical chemistry 2009;402(1-2):189-92.
-
2009: Everett B M; Glynn R J; Buring J E; Ridker P M
Lipid biomarkers, hormone therapy and the risk of venous thromboembolism in women.
Journal of thrombosis and haemostasis : JTH 2009;7(4):588-96.
-
2009: Chasman Daniel I; Shiffman Dov; Zee Robert Y L; Louie Judy Z; Luke May M; Rowland Charles M; Catanese Joseph J; Buring Julie E; Devlin James J; Ridker Paul M
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy.
Atherosclerosis 2009;203(2):371-6.
-
2009: Conen David; Cheng Suzanne; Steiner Lori L; Buring Julie E; Ridker Paul M; Zee Robert Y L
Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the Women's Genome Health Study.
Journal of hypertension 2009;27(3):476-83.
-
2009: Wang Xingyu; Cheng Suzanne; Brophy Victoria H; Erlich Henry A; Mannhalter Christine; Berger Klaus; Lalouschek Wolfgang; Browner Warren S; Shi Yu; Ringelstein E Bernd; Kessler Christof; Luedemann Jan; Lindpaintner Klaus; Liu Lisheng; Ridker Paul M; Zee Robert Y L; Cook Nancy R;
A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients.
Stroke; a journal of cerebral circulation 2009;40(3):683-95.
-
2009: Ray Kausik K; Cannon Christopher P; Cairns Richard; Morrow David A; Ridker Paul M; Braunwald Eugene
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Arteriosclerosis, thrombosis, and vascular biology 2009;29(3):424-30.
-
2009: Mora Samia; Otvos James D; Rifai Nader; Rosenson Robert S; Buring Julie E; Ridker Paul M
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
Circulation 2009;119(7):931-9.
-
2009: Schürks Markus; Kurth Tobias; Ridker Paul M; Buring Julie E; Zee Robert Y L
Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women.
Thrombosis and haemostasis 2009;101(2):351-8.
-
2009: Ridker Paul M
Myocardial infarction in a 72-year-old woman with low LDL-C and increased hsCRP: implications for statin therapy.
Clinical chemistry 2009;55(2):369-74; discussion 374-5.
-
2009: Itsara Andy; Cooper Gregory M; Baker Carl; Girirajan Santhosh; Li Jun; Absher Devin; Krauss Ronald M; Myers Richard M; Ridker Paul M; Chasman Daniel I; Mefford Heather; Ying Phyllis; Nickerson Deborah A; Eichler Evan E
Population analysis of large copy number variants and hotspots of human genetic disease.
American journal of human genetics 2009;84(2):148-61.
-
2009: Glynn Robert J; MacFadyen Jean G; Ridker Paul M
Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study.
Clinical chemistry 2009;55(2):305-12.
-
2009: Ridker Paul M
C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease.
Clinical chemistry 2009;55(2):209-15.
-
2009: Meyer Tamra E; Shiffman Dov; Morrison Alanna C; Rowland Charles M; Louie Judy Z; Bare Lance A; Ross David A; Arellano Andre R; Chasman Daniel I; Ridker Paul M; Pankow James S; Coresh Josef; Malloy Mary J; Kane John P; Ellis Stephen G; Devlin James J; Boerwinkle Eric
GOSR2 Lys67Arg is associated with hypertension in whites.
American journal of hypertension 2009;22(2):163-8.
-
2009: Schürks Markus; Kurth Tobias; Ridker Paul M; Buring Julie E; Zee Robert Y L
Association between polymorphisms in the beta2-adrenoceptor gene and migraine in women.
Headache 2009;49(2):235-44.
-
2009: Paynter Nina P; Chasman Daniel I; Buring Julie E; Shiffman Dov; Cook Nancy R; Ridker Paul M
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.
Annals of internal medicine 2009;150(2):65-72.
-
2009: Pradhan Aruna D; Cook Nancy R; Manson Joann E; Ridker Paul M; Buring Julie E
A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women.
Diabetes care 2009;32(1):3-8.
-
2009: Everett Brendan M; Bansal Sandeep; Rifai Nader; Buring Julie E; Ridker Paul M
Interleukin-18 and the risk of future cardiovascular disease among initially healthy women.
Atherosclerosis 2009;202(1):282-8.
-
2009: Kurth Tobias; de Jong Paul E; Cook Nancy R; Buring Julie E; Ridker Paul M
Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study.
BMJ (Clinical research ed.) 2009;338():b2392.
-
2008: Friedewald Vincent E; Cather Jennifer C; Gelfand Joel M; Gordon Kenneth B; Gibbons Gary H; Grundy Scott M; Jarratt Michael T; Krueger James G; Ridker Paul M; Stone Neil; Roberts William C
AJC editor's consensus: psoriasis and coronary artery disease.
The American journal of cardiology 2008;102(12):1631-43.
-
2008: Lin Julie; Glynn Robert J; Rifai Nader; Manson JoAnn E; Ridker Paul M; Nathan David M; Schaumberg Debra A
Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial.
Diabetes care 2008;31(12):2338-43.
-
2008: Ridker Paul M; Danielson Eleanor; Fonseca Francisco A H; Genest Jacques; Gotto Antonio M; Kastelein John J P; Koenig Wolfgang; Libby Peter; Lorenzatti Alberto J; MacFadyen Jean G; Nordestgaard Børge G; Shepherd James; Willerson James T; Glynn Robert J;
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
The New England journal of medicine 2008;359(21):2195-207.
-
2008: Ridker Paul M; Paynter Nina P; Rifai Nader; Gaziano J Michael; Cook Nancy R
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men.
Circulation 2008;118(22):2243-51, 4p following 2251.
-
2008: Zee Robert Y L; Hennessey Hooman; Michaud Sherri E; Ridker Paul M
Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach.
Atherosclerosis 2008;201(1):124-9.
-
2008: Conen David; Torres Jose; Ridker Paul M
Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
Circulation 2008;118(13):1321-7.
-
2008: Mora Samia; Rifai Nader; Buring Julie E; Ridker Paul M
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
Circulation 2008;118(10):993-1001.
-
2008: Conen David; Glynn Robert J; Buring Julie E; Ridker Paul M; Zee Robert Y L
Association of renin-angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study.
Journal of hypertension 2008;26(9):1780-6.
-
2008: Gage B F; Eby C; Johnson J A; Deych E; Rieder M J; Ridker P M; Milligan P E; Grice G; Lenzini P; Rettie A E; Aquilante C L; Grosso L; Marsh S; Langaee T; Farnett L E; Voora D; Veenstra D L; Glynn R J; Barrett A; McLeod H L
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin.
Clinical pharmacology and therapeutics 2008;84(3):326-31.
-
2008: Eaton Charles B; Gramling Robert; Parker Donna R; Roberts Mary B; Lu Bing; Ridker Paul M
Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in southeastern New England.
Atherosclerosis 2008;200(1):221-7.
-
2008: Ridker Paul M; Silvertown Josh D
Inflammation, C-reactive protein, and atherothrombosis.
Journal of periodontology 2008;79(8 Suppl):1544-51.
-
2008: Paschou Peristera; Drineas Petros; Lewis Jamey; Nievergelt Caroline M; Nickerson Deborah A; Smith Joshua D; Ridker Paul M; Chasman Daniel I; Krauss Ronald M; Ziv Elad
Tracing sub-structure in the European American population with PCA-informative markers.
PLoS genetics 2008;4(7):e1000114.
-
2008: Paré Guillaume; Chasman Daniel I; Kellogg Mark; Zee Robert Y L; Rifai Nader; Badola Sunita; Miletich Joseph P; Ridker Paul M
Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women.
PLoS genetics 2008;4(7):e1000118.
-
2008: Suk Danik Jacqueline; Rifai Nader; Buring Julie E; Ridker Paul M
Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.
Journal of the American College of Cardiology 2008;52(2):124-31.
-
2008: Ridker Paul M
The time for cardiovascular inflammation reduction trials has arrived: how low to go for hsCRP?
Arteriosclerosis, thrombosis, and vascular biology 2008;28(7):1222-4.
-
2008: King Cristi R; Porche-Sorbet Rhonda M; Gage Brian F; Ridker Paul M; Renaud Yannick; Phillips Michael S; Eby Charles
Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose.
American journal of clinical pathology 2008;129(6):876-83.
-
2008: Reiner Alexander P; Barber Mathew J; Guan Yongtao; Ridker Paul M; Lange Leslie A; Chasman Daniel I; Walston Jeremy D; Cooper Gregory M; Jenny Nancy S; Rieder Mark J; Durda J Peter; Smith Joshua D; Novembre John; Tracy Russell P; Rotter Jerome I; Stephens Matthew; Nickerson Deborah A; Krauss Ronald M
Polymorphisms of the HNF1A gene encoding hepatocyte nuclear factor-1 alpha are associated with C-reactive protein.
American journal of human genetics 2008;82(5):1193-201.
-
2008: Ridker Paul M; Pare Guillaume; Parker Alex; Zee Robert Y L; Danik Jacqueline S; Buring Julie E; Kwiatkowski David; Cook Nancy R; Miletich Joseph P; Chasman Daniel I
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.
American journal of human genetics 2008;82(5):1185-92.
-
2008: Mälarstig Anders; Eriksson Per; Rose Lynda; Diehl Kirsti A; Hamsten Anders; Ridker Paul M; Zee Robert Y L
Genetic variants of tumor necrosis factor superfamily, member 4 (TNFSF4), and risk of incident atherothrombosis and venous thromboembolism.
Clinical chemistry 2008;54(5):833-40.
-
2008: Rexrode Kathryn M; Ridker Paul M; Hegener Hillary H; Buring Julie E; Manson JoAnn E; Zee Robert Y L
Genetic variation of the androgen receptor and risk of myocardial infarction and ischemic stroke in women.
Stroke; a journal of cerebral circulation 2008;39(5):1590-2.
-
2008: Everett Brendan M; Glynn Robert J; Danielson Eleanor; Ridker Paul M;
Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
Clinical therapeutics 2008;30(4):661-72.
-
2008: Friedewald Vincent E; Cather Jennifer C; Gordon Kenneth B; Kavanaugh Arthur; Ridker Paul M; Roberts William C
The editor's roundtable: psoriasis, inflammation, and coronary artery disease.
The American journal of cardiology 2008;101(8):1119-26.
-
2008: Zee Robert Y L; Germer Soren; Thomas Abraham; Raji Annaswammy; Rhees Brian; Ridker Paul M; Lindpaintner Klaus; Williams Gordon H; Nathan David M; Martin Mitchell
C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study.
Atherosclerosis 2008;197(2):931-6.
-
2008: Zee Robert Y L; Michaud Sherri E; Diehl Kirsti A; Chasman Daniel I; Emmerich Joseph; Gaussem Pascale; Aiach Martine; Ridker Paul M
Purinergic receptor P2Y, G-protein coupled, 12 gene variants and risk of incident ischemic stroke, myocardial infarction, and venous thromboembolism.
Atherosclerosis 2008;197(2):694-9.
-
2008: Emmerich Joseph; Ridker Paul M
Can fishing for new genes catch patients at risk of coronary artery disease?
Clinical chemistry 2008;54(3):453-5.
-
2008: Levitan Emily B; Cook Nancy R; Stampfer Meir J; Ridker Paul M; Rexrode Kathryn M; Buring Julie E; Manson JoAnn E; Liu Simin
Dietary glycemic index, dietary glycemic load, blood lipids, and C-reactive protein.
Metabolism: clinical and experimental 2008;57(3):437-43.
-
2008: Albert Michelle A; Glynn Robert J; Buring Julie E; Ridker Paul M
Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study.
Atherosclerosis 2008;197(1):297-302.
-
2008: Pradhan Aruna D; Shrivastava Sanjay; Cook Nancy R; Rifai Nader; Creager Mark A; Ridker Paul M
Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk.
Circulation 2008;117(6):823-31.
-
2008: Ridker Paul M
High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care.
Clinical chemistry 2008;54(2):234-7.
-
2008: Ridker Paul M; Chasman Daniel I; Zee Robert Y L; Parker Alex; Rose Lynda; Cook Nancy R; Buring Julie E;
Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women.
Clinical chemistry 2008;54(2):249-55.
-
2008: Shiffman Dov; Chasman Daniel I; Zee Robert Y L; Iakoubova Olga A; Louie Judy Z; Devlin James J; Ridker Paul M
A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study.
Journal of the American College of Cardiology 2008;51(4):444-8.
-
2008: Vidula Himabindu; Tian Lu; Liu Kiang; Criqui Michael H; Ferrucci Luigi; Pearce William H; Greenland Philip; Green David; Tan Jin; Garside Daniel B; Guralnik Jack; Ridker Paul M; Rifai Nader; McDermott Mary M
Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study.
Annals of internal medicine 2008;148(2):85-93.
-
2008: Kardys Isabella; Rifai Nader; Meilhac Olivier; Michel Jean-Baptiste; Martin-Ventura Jose Luis; Buring Julie E; Libby Peter; Ridker Paul M
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study.
Clinical chemistry 2008;54(1):139-46.
-
2008: Ridker Paul M
Fasting versus nonfasting triglycerides and the prediction of cardiovascular risk: do we need to revisit the oral triglyceride tolerance test?
Clinical chemistry 2008;54(1):11-3.
-
2007: Ridker Paul M
Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.
Nutrition reviews 2007;65(12 Pt 2):S253-9.
-
2007: Ridker Paul M; Fonseca Francisco A H; Genest Jacques; Gotto Antonio M; Kastelein John J P; Khurmi Nardev S; Koenig Wolfgang; Libby Peter; Lorenzatti Alberto J; Nordestgaard Borge G; Shepherd James; Willerson James T; Glynn Robert J;
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.
The American journal of cardiology 2007;100(11):1659-64.
-
2007: Song Yiqing; Manson JoAnn E; Meigs James B; Ridker Paul M; Buring Julie E; Liu Simin
Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women.
The American journal of cardiology 2007;100(11):1654-8.
-
2007: Conen David; Glynn Robert J; Buring Julie E; Ridker Paul M; Zee Robert Y L
Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension.
Hypertension 2007;50(6):1114-9.
-
2007: Zee Robert Y L; Cheng Suzanne; Erlich Henry A; Lindpaintner Klaus; Rifai Nader; Buring Julie E; Ridker Paul M
Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women.
Stroke; a journal of cerebral circulation 2007;38(12):3152-7.
-
2007: Conen David; Ridker Paul M; Mora Samia; Buring Julie E; Glynn Robert J
Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study.
European heart journal 2007;28(23):2937-43.
-
2007: Mora Samia; Cook Nancy; Buring Julie E; Ridker Paul M; Lee I-Min
Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms.
Circulation 2007;116(19):2110-8.
-
2007: Glynn Robert J; Ridker Paul M; Goldhaber Samuel Z; Buring Julie E
Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial.
Annals of internal medicine 2007;147(8):525-33.
-
2007: Zee Robert Y L; Ridker Paul M
Two common gene variants on chromosome 9 and risk of atherothrombosis.
Stroke; a journal of cerebral circulation 2007;38(10):e111.
-
2007: Rexrode Kathryn M; Ridker Paul M; Hegener Hillary H; Buring Julie E; Manson Joann E; Zee Robert Y L
Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women.
Clinical chemistry 2007;53(10):1749-56.
-
2007: Danik Jacqueline Suk; Ridker Paul M
Genetic determinants of C-reactive protein.
Current atherosclerosis reports 2007;9(3):195-203.
-
2007: Glynn Robert J; Ridker Paul M; Goldhaber Samuel Z; Zee Robert Y L; Buring Julie E
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Circulation 2007;116(13):1497-503.
-
2007: Conen David; Ridker Paul M; Buring Julie E; Glynn Robert J
Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study.
BMJ (Clinical research ed.) 2007;335(7617):432.
-
2007: Pradhan Aruna D; Rifai Nader; Buring Julie E; Ridker Paul M
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women.
The American journal of medicine 2007;120(8):720-7.
-
2007: Bansal Sandeep; Buring Julie E; Rifai Nader; Mora Samia; Sacks Frank M; Ridker Paul M
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.
JAMA : the journal of the American Medical Association 2007;298(3):309-16.
-
2007: Song Yiqing; Manson JoAnn E; Tinker Lesley; Rifai Nader; Cook Nancy R; Hu Frank B; Hotamisligil Gokhan S; Ridker Paul M; Rodriguez Beatriz L; Margolis Karen L; Oberman Albert; Liu Simin
Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women.
Diabetes 2007;56(7):1898-904.
-
2007: Zhang Shumin M; Lin Jennifer; Cook Nancy R; Lee I-Min; Manson JoAnn E; Buring Julie E; Ridker Paul M
C-reactive protein and risk of breast cancer.
Journal of the National Cancer Institute 2007;99(11):890-4.
-
2007: Bansal Sandeep; Ridker Paul M
Comparison of characteristics of future myocardial infarctions in women with baseline high versus baseline low levels of high-sensitivity C-reactive protein.
The American journal of cardiology 2007;99(11):1500-3.
-
2007: Ridker Paul M
C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus.
Journal of the American College of Cardiology 2007;49(21):2129-38.
-
2007: Ridker Paul M; Everett Brendan M
Letter by Ridker and Everett regarding article, "The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?".
Circulation 2007;115(20):e475; author reply e476.
-
2007: Albert Michelle A; Glynn Robert J; Buring Julie E; Ridker Paul M
Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease.
The American journal of cardiology 2007;99(9):1246-51.
-
2007: Huang Peng-yun A; Buring Julie E; Ridker Paul M; Glynn Robert J
Awareness, accuracy, and predictive validity of self-reported cholesterol in women.
Journal of general internal medicine 2007;22(5):606-13.
-
2007: Zee Robert Y L; Mora Samia; Cheng Suzanne; Erlich Henry A; Lindpaintner Klaus; Rifai Nader; Buring Julie E; Ridker Paul M
Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.
Clinical chemistry 2007;53(5):845-51.
-
2007: Miller David T; Ridker Paul M; Libby Peter; Kwiatkowski David J
Atherosclerosis: the path from genomics to therapeutics.
Journal of the American College of Cardiology 2007;49(15):1589-99.
-
2007: Ridker Paul M; Cook Nancy R
Biomarkers for prediction of cardiovascular events.
The New England journal of medicine 2007;356(14):1472-3; author reply 1474-5.
-
2007: Sabatine Marc S; Morrow David A; Jablonski Kathleen A; Rice Madeline Murguia; Warnica J Wayne; Domanski Michael J; Hsia Judith; Gersh Bernard J; Rifai Nader; Ridker Paul M; Pfeffer Marc A; Braunwald Eugene;
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Circulation 2007;115(12):1528-36.
-
2007: Schaumberg Debra A; Christen William G; Buring Julie E; Glynn Robert J; Rifai Nader; Ridker Paul M
High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women.
Archives of ophthalmology 2007;125(3):300-5.
-
2007: Ridker Paul M; Buring Julie E; Rifai Nader; Cook Nancy R
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.
JAMA : the journal of the American Medical Association 2007;297(6):611-9.
-
2007: Sesso Howard D; Wang Lu; Buring Julie E; Ridker Paul M; Gaziano J Michael
Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women.
Hypertension 2007;49(2):304-10.
-
2007: Glynn Robert J; Goldhaber Samuel Z; Ridker Paul M
D-dimer and duration of anticoagulation.
The New England journal of medicine 2007;356(4):422-3; author reply 423.
-
2007: Owens Christopher D; Ridker Paul M; Belkin Michael; Hamdan Allen D; Pomposelli Frank; Logerfo Frank; Creager Mark A; Conte Michael S
Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
Journal of vascular surgery : official publication, the Society for Vascular Surgery [and] International Society for Cardiovascular Surgery, North American Chapter 2007;45(1):2-9; discussion 9.
-
2006: Everett Brendan M; Kurth Tobias; Buring Julie E; Ridker Paul M
The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women.
Journal of the American College of Cardiology 2006;48(11):2235-42.
-
2006: Shadick Nancy A; Cook Nancy R; Karlson Elizabeth W; Ridker Paul M; Maher Nancy E; Manson Joann E; Buring Julie E; Lee I-Min
C-reactive protein in the prediction of rheumatoid arthritis in women.
Archives of internal medicine 2006;166(22):2490-4.
-
2006: Albert Michelle A; Glynn Robert J; Buring Julie; Ridker Paul M
Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.
Circulation 2006;114(24):2619-26.
-
2006: Weinberg Melissa E; Manson JoAnn E; Buring Julie E; Cook Nancy R; Seely Ellen W; Ridker Paul M; Rexrode Kathryn M
Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women.
Metabolism: clinical and experimental 2006;55(11):1473-80.
-
2006: Suk Danik J; Chasman D I; Cannon C P; Miller D T; Zee R Y L; Kozlowski P; Kwiatkowski D J; Ridker P M
Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.
Annals of human genetics 2006;70(Pt 6):705-16.
-
2006: Hegener Hillary H; Lee I-Min; Cook Nancy R; Ridker Paul M; Zee Robert Y L
Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study.
Clinical chemistry 2006;52(11):2021-7.
-
2006: Suk Danik Jacqueline; Rifai Nader; Buring Julie E; Ridker Paul M
Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
JAMA : the journal of the American Medical Association 2006;296(11):1363-70.
-
2006: Zee R Y L; Michaud S E; Hegener H H; Diehl K A; Ridker P M
A prospective replication study of five gene variants previously associated with risk of myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2006;4(9):2093-5.
-
2006: Kozlowski Piotr; Miller David T; Zee Robert Y L; Danik Jacqueline Suk; Chasman Daniel I; Lazarus Ross; Cook Nancy R; Ridker Paul M; Kwiatkowski David J
Lack of association between genetic variation in 9 innate immunity genes and baseline CRP levels.
Annals of human genetics 2006;70(Pt 5):574-86.
-
2006: Albert Michelle A; Ridker Paul M
C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference?
Circulation 2006;114(5):e67-74.
-
2006: Hegener H H; Diehl K A; Kurth T; Gaziano J M; Ridker P M; Zee R Y L
Polymorphisms of prostaglandin-endoperoxide synthase 2 gene, and prostaglandin-E receptor 2 gene, C-reactive protein concentrations and risk of atherothrombosis: a nested case-control approach.
Journal of thrombosis and haemostasis : JTH 2006;4(8):1718-22.
-
2006: Mora Samia; Rifai Nader; Buring Julie E; Ridker Paul M
Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events.
Circulation 2006;114(5):381-7.
-
2006: Zee Robert Y L; Brophy Victoria H; Cheng Suzanne; Hegener Hillary H; Erlich Henry A; Ridker Paul M
Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation.
Stroke; a journal of cerebral circulation 2006;37(8):2012-7.
-
2006: Mega Jessica L; Morrow David A; Cannon Christopher P; Murphy Sabina; Cairns Richard; Ridker Paul M; Braunwald Eugene
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy.
Journal of thrombosis and thrombolysis 2006;22(1):71-6.
-
2006: Zee Robert Y L; Cheng Suzanne; Hegener Hillary H; Erlich Henry A; Ridker Paul M
Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach.
Stroke; a journal of cerebral circulation 2006;37(8):2007-11.
-
2006: Zee Robert Y L; Diehl Kirsti A; Ridker Paul M
Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study.
Atherosclerosis 2006;187(2):332-5.
-
2006: Ridker Paul M; Cook Nancy R; Buring Julie E
Use of aspirin as primary prevention of cardiovascular events.
JAMA : the journal of the American Medical Association 2006;296(4):391; author reply 391-2.
-
2006: Cook Nancy R; Buring Julie E; Ridker Paul M
The effect of including C-reactive protein in cardiovascular risk prediction models for women.
Annals of internal medicine 2006;145(1):21-9.
-
2006: Zee Robert Y L; Romero Jose R; Gould Jessica L; Ricupero Dennis A; Ridker Paul M
Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke.
Stroke; a journal of cerebral circulation 2006;37(7):1686-90.
-
2006: Ridker Paul M; Danielson Eleanor; Rifai Nader; Glynn Robert J;
Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial.
Hypertension 2006;48(1):73-9.
-
2006: Ridker Paul M
Incomplete financial disclosure for study of funding and outcomes in major cardiovascular trials.
JAMA : the journal of the American Medical Association 2006;295(23):2725-6.
-
2006: Aboyans Victor; Criqui Michael H; Denenberg Julie O; Knoke James D; Ridker Paul M; Fronek Arnost
Risk factors for progression of peripheral arterial disease in large and small vessels.
Circulation 2006;113(22):2623-9.
-
2006: Schaumberg Debra A; Christen William G; Kozlowski Piotr; Miller David T; Ridker Paul M; Zee Robert Y L
A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration.
Investigative ophthalmology & visual science 2006;47(6):2336-40.
-
2006: Shrivastava S; Ridker P M; Glynn R J; Goldhaber S Z; Moll S; Bounameaux H; Bauer K A; Kessler C M; Cushman M
D-dimer, factor VIII coagulant activity, low-intensity warfarin and the risk of recurrent venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1208-14.
-
2006: Ridker Paul M; Torres Jose
Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005.
JAMA : the journal of the American Medical Association 2006;295(19):2270-4.
-
2006: Healy Aileen M; Pickard Michael D; Pradhan Aruna D; Wang Yunmei; Chen Zhiping; Croce Kevin; Sakuma Masashi; Shi Can; Zago Alexandre C; Garasic Joseph; Damokosh Andrew I; Dowie Tracy L; Poisson Louis; Lillie James; Libby Peter; Ridker Paul M; Simon Daniel I
Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events.
Circulation 2006;113(19):2278-84.
-
2006: Rodenburg Jessica; Vissers Maud N; Wiegman Albert; Miller Elizabeth R; Ridker Paul M; Witztum Joseph L; Kastelein John J P; Tsimikas Sotirios
Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Journal of the American College of Cardiology 2006;47(9):1803-10.
-
2006: Zee Robert Y L; Cook Nancy R; Cheng Suzanne; Erlich Henry A; Lindpaintner Klaus; Ridker Paul M
Polymorphism in the beta2-adrenergic receptor and lipoprotein lipase genes as risk determinants for idiopathic venous thromboembolism: a multilocus, population-based, prospective genetic analysis.
Circulation 2006;113(18):2193-200.
-
2006: Tsimikas Sotirios; Willerson James T; Ridker Paul M
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
Journal of the American College of Cardiology 2006;47(8 Suppl):C19-31.
-
2006: McDermott Mary M; Liu Kiang; Guralnik Jack M; Ferrucci Luigi; Green David; Greenland Philip; Tian Lu; Criqui Michael H; Lo Carol; Rifai Nader; Ridker Paul M; Zheng Jane; Pearce William
Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer.
The journals of gerontology. Series A, Biological sciences and medical sciences 2006;61(4):374-9.
-
2006: Chasman D I; Kozlowski P; Zee R Y; Kwiatkowski D J; Ridker P M
Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein.
Genes and immunity 2006;7(3):211-9.
-
2006: Mora Samia; Lee I-Min; Buring Julie E; Ridker Paul M
Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
JAMA : the journal of the American Medical Association 2006;295(12):1412-9.
-
2006: Lin Jennifer; Ridker Paul M; Rifai Nader; Lee I-Min; Manson JoAnn E; Buring Julie E; Zhang Shumin M
A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women.
Cancer research 2006;66(5):2869-75.
-
2006: Weuve Jennifer; Ridker Paul M; Cook Nancy R; Buring Julie E; Grodstein Francine
High-sensitivity C-reactive protein and cognitive function in older women.
Epidemiology (Cambridge, Mass.) 2006;17(2):183-9.
-
2006: Zee R Y L; Cook N R; Cheng S; Erlich H A; Lindpaintner K; Ridker P M
Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis.
Journal of thrombosis and haemostasis : JTH 2006;4(2):341-8.
-
2006: Chiang Nan; Hurwitz Shelley; Ridker Paul M; Serhan Charles N
Aspirin has a gender-dependent impact on antiinflammatory 15-epi-lipoxin A4 formation: a randomized human trial.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):e14-7.
-
2006: Joffe Hylton V; Ridker Paul M; Manson Joann E; Cook Nancy R; Buring Julie E; Rexrode Kathryn M
Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
Annals of epidemiology 2006;16(2):105-12.
-
2006: Mora Samia; Ridker Paul M
Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
The American journal of cardiology 2006;97(2A):33A-41A.
-
2006: Ndumele Chiadi E; Pradhan Aruna D; Ridker Paul M
Interrelationships between inflammation, C-reactive protein, and insulin resistance.
Journal of the cardiometabolic syndrome 2006;1(3):190-6.
-
2005: Lin Jennifer; Ridker Paul M; Pradhan Aruna; Lee I-Min; Manson JoAnn E; Cook Nancy R; Buring Julie E; Zhang Shumin M
Hemoglobin A1c concentrations and risk of colorectal cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(12):3010-2.
-
2005: Zee R Y L; Hegener H H; Ridker P M
Carboxypeptidase B2 gene polymorphisms and the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2819-21.
-
2005: Jain Mukesh K; Ridker Paul M
Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
Nature reviews. Drug discovery 2005;4(12):977-87.
-
2005: Liu Simin; Song Yiqing; Ford Earl S; Manson JoAnn E; Buring Julie E; Ridker Paul M
Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women.
Diabetes care 2005;28(12):2926-32.
-
2005: Shrivastava Sanjay; Ridker Paul M
Low dose.
Clinical advances in hematology & oncology : H&O 2005;3(11):880-1.
-
2005: Sesso Howard D; Buring Julie E; Chown Marilyn J; Ridker Paul M; Gaziano J Michael
A prospective study of plasma lipid levels and hypertension in women.
Archives of internal medicine 2005;165(20):2420-7.
-
2005: Beckman Joshua A; Preis Ori; Ridker Paul M; Gerhard-Herman Marie
Comparison of usefulness of inflammatory markers in patients with versus without peripheral arterial disease in predicting adverse cardiovascular outcomes (myocardial infarction, stroke, and death).
The American journal of cardiology 2005;96(10):1374-8.
-
2005: Miller D T; Zee R Y L; Suk Danik J; Kozlowski P; Chasman D I; Lazarus R; Cook N R; Ridker P M; Kwiatkowski D J
Association of common CRP gene variants with CRP levels and cardiovascular events.
Annals of human genetics 2005;69(Pt 6):623-38.
-
2005: Rosner Sarah A; Ridker Paul M; Zee Robert Y L; Cook Nancy R
Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician's Health Study.
Human genetics 2005;118(2):287-94.
-
2005: Ray Kausik K; Cannon Christopher P; Cairns Richard; Morrow David A; Rifai Nader; Kirtane Ajay J; McCabe Carolyn H; Skene Allan M; Gibson C Michael; Ridker Paul M; Braunwald Eugene;
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Journal of the American College of Cardiology 2005;46(8):1417-24.
-
2005: McDermott Mary M; Ferrucci Luigi; Liu Kiang; Criqui Michael H; Greenland Philip; Green David; Guralnik Jack M; Ridker Paul M; Taylor Lloyd M; Rifai Nader; Tian Lu; Zheng Jane; Pearce William H; Schneider Joseph R; Vonesh Ed
D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease.
Journal of the American Geriatrics Society 2005;53(10):1688-96.
-
2005: Albert Michelle A; Glynn Robert J; Wolfert Robert L; Ridker Paul M
The effect of statin therapy on lipoprotein associated phospholipase A2 levels.
Atherosclerosis 2005;182(1):193-8.
-
2005: Bassuk Shari S; Ridker Paul M; Manson Joann E; Buring Julie E
Aspirin and cardiovascular disease prevention in women: new findings from the Women's Health Study.
Women's health (London, England) 2005;1(1):9-10.
-
2005: Marroquin Oscar C; Kip Kevin E; Mulukutla Suresh R; Ridker Paul M; Pepine Carl J; Tjandrawan Tjendimin; Kelsey Sheryl F; Mankad Sunil; Rogers William J; Merz C Noel Bairey; Sopko George; Sharaf Barry L; Reis Steven E
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease.
American heart journal 2005;150(1):109-15.
-
2005: Ridker Paul M; Rifai Nader; Cook Nancy R; Bradwin Gary; Buring Julie E
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.
JAMA : the journal of the American Medical Association 2005;294(3):326-33.
-
2005: Ridker Paul M
C-reactive protein in 2005. Interview by Peter C. Block.
Journal of the American College of Cardiology 2005;46(1):CS2-5.
-
2005: Lee I-Min; Cook Nancy R; Gaziano J Michael; Gordon David; Ridker Paul M; Manson Joann E; Hennekens Charles H; Buring Julie E
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(1):56-65.
-
2005: Cook Nancy R; Lee I-Min; Gaziano J Michael; Gordon David; Ridker Paul M; Manson JoAnn E; Hennekens Charles H; Buring Julie E
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2005;294(1):47-55.
-
2005: Levitan Emily B; Ridker Paul M; Manson JoAnn E; Stampfer Meir J; Buring Julie E; Cook Nancy R; Liu Simin
Association between consumption of beer, wine, and liquor and plasma concentration of high-sensitivity C-reactive protein in women aged 39 to 89 years.
The American journal of cardiology 2005;96(1):83-8.
-
2005: Zee Robert Y L; Hegener Hillary H; Chasman Daniel I; Ridker Paul M
Tryptophanyl-tRNA synthetase gene polymorphisms and risk of incident myocardial infarction.
Atherosclerosis 2005;181(1):137-41.
-
2005: Langer Robert D; Pradhan Aruna D; Lewis Cora E; Manson JoAnn E; Rossouw Jacques E; Hendrix Susan L; LaCroix Andrea Z; Ridker Paul M
Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The Women's Health Initiative Observational Study.
Thrombosis and haemostasis 2005;93(6):1108-16.
-
2005: Song Yiqing; Ridker Paul M; Manson JoAnn E; Cook Nancy R; Buring Julie E; Liu Simin
Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women.
Diabetes care 2005;28(6):1438-44.
-
2005: Ridker Paul M; Morrow David A; Rose Lynda M; Rifai Nader; Cannon Christopher P; Braunwald Eugene
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
Journal of the American College of Cardiology 2005;45(10):1644-8.
-
2005: Schaumberg Debra A; Glynn Robert J; Jenkins Alicia J; Lyons Timothy J; Rifai Nader; Manson JoAnn E; Ridker Paul M; Nathan David M
Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
Circulation 2005;111(19):2446-53.
-
2005: Zhang Shumin M; Buring Julie E; Lee I-Min; Cook Nancy R; Ridker Paul M
C-reactive protein levels are not associated with increased risk for colorectal cancer in women.
Annals of internal medicine 2005;142(6):425-32.
-
2005: Ridker Paul M; Cook Nancy R; Lee I-Min; Gordon David; Gaziano J Michael; Manson Joann E; Hennekens Charles H; Buring Julie E
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
The New England journal of medicine 2005;352(13):1293-304.
-
2005: Zee Robert Y L; Cook Nancy R; Reynolds Rebecca; Cheng Suzanne; Ridker Paul M
Haplotype analysis of the beta2 adrenergic receptor gene and risk of myocardial infarction in humans.
Genetics 2005;169(3):1583-7.
-
2005: Ridker Paul M; Cook Nancy
Should age and time be eliminated from cardiovascular risk prediction models? Rationale for the creation of a new national risk detection program.
Circulation 2005;111(5):657-8.
-
2005: Verma Subodh; Szmitko Paul E; Ridker Paul M
C-reactive protein comes of age.
Nature clinical practice. Cardiovascular medicine 2005;2(1):29-36; quiz 58.
-
2005: Chasman Daniel I; Ridker Paul M
Pharmacogenetics: the outlook for genetic testing in statin therapy.
Nature clinical practice. Cardiovascular medicine 2005;2(1):2-3.
-
2005: Ridker Paul M; Cannon Christopher P; Morrow David; Rifai Nader; Rose Lynda M; McCabe Carolyn H; Pfeffer Marc A; Braunwald Eugene;
C-reactive protein levels and outcomes after statin therapy.
The New England journal of medicine 2005;352(1):20-8.
-
2005: Suk H Jacqueline; Ridker Paul M; Cook Nancy R; Zee Robert Y L
Relation of polymorphism within the C-reactive protein gene and plasma CRP levels.
Atherosclerosis 2005;178(1):139-45.
-
2005: Zee Robert Y L; Hegener Hillary H; Gould Jessica; Ridker Paul M
Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis.
Stroke; a journal of cerebral circulation 2005;36(1):154-7.
-
2005: Ridker Paul M
C-reactive protein, inflammation, and cardiovascular disease: clinical update.
Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital 2005;32(3):384-6.
-
2004: Engler M M; Engler M B; Malloy M; Chiu E; Besio D; Paul S; Stuehlinger M; Morrow J; Ridker P; Rifai N; Mietus-Snyder M
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study.
International journal of clinical pharmacology and therapeutics 2004;42(12):672-9.
-
2004: Smith Sidney C; Anderson Jeffrey L; Cannon Richard O; Fadl Yazid Y; Koenig Wolfgang; Libby Peter; Lipshultz Steven E; Mensah George A; Ridker Paul M; Rosenson Robert;
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
Circulation 2004;110(25):e550-3.
-
2004: McDermott Mary M; Guralnik Jack M; Greenland Philip; Green David; Liu Kiang; Ridker Paul M; Chan Cheeling; Criqui Michael H; Ferrucci Luigi; Taylor Lloyd M; Pearce William H; Schneider Joseph R; Oskin Sarah I
Inflammatory and thrombotic blood markers and walking-related disability in men and women with and without peripheral arterial disease.
Journal of the American Geriatrics Society 2004;52(11):1888-94.
-
2004: Chiang Nan; Bermudez Edmund A; Ridker Paul M; Hurwitz Shelley; Serhan Charles N
Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(42):15178-83.
-
2004: Zee R Y L; Hegener H H; Cook N R; Ridker P M
C-reactive protein gene polymorphisms and the risk of venous thromboembolism: a haplotype-based analysis.
Journal of thrombosis and haemostasis : JTH 2004;2(8):1240-3.
-
2004: Bassuk Shari S; Rifai Nader; Ridker Paul M
High-sensitivity C-reactive protein: clinical importance.
Current problems in cardiology 2004;29(8):439-93.
-
2004: Rifai Nader; Ma Jing; Sacks Frank M; Ridker Paul M; Hernandez Wendy Jade L; Stampfer Meir J; Marcovina Santica M
Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
Clinical chemistry 2004;50(8):1364-71.
-
2004: Ridker Paul M; Koenig Wolfgang; Fuster Valentin
C-reactive protein and coronary heart disease.
The New England journal of medicine 2004;351(3):295-8; author reply 295-8.
-
2004: Albert Michelle A; Torres Jose; Glynn Robert J; Ridker Paul M
Perspective on selected issues in cardiovascular disease research with a focus on black Americans.
Circulation 2004;110(2):e7-12.
-
2004: Pradhan Aruna D; LaCroix Andrea Z; Langer Robert D; Trevisan Maurizio; Lewis Cora E; Hsia Judith A; Oberman Albert; Kotchen Jane M; Ridker Paul M
Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Circulation 2004;110(3):292-300.
-
2004: Ridker P M
Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes.
Journal of thrombosis and haemostasis : JTH 2004;2(7):1034-7.
-
2004: Ridker Paul M
High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
American heart journal 2004;148(1 Suppl):S19-26.
-
2004: Zee Robert Y L; Cook Nancy R; Cheng Suzanne; Erlich Henry A; Lindpaintner Klaus; Lee Richard T; Ridker Paul M
Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction.
Atherosclerosis 2004;175(1):91-4.
-
2004: Ridker Paul M; Brown Nancy J; Vaughan Douglas E; Harrison David G; Mehta Jawahar L
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.
Circulation 2004;109(25 Suppl 1):IV6-19.
-
2004: Stampfer Meir J; Ridker Paul M; Dzau Victor J
Risk factor criteria.
Circulation 2004;109(25 Suppl 1):IV3-5.
-
2004: Chasman Daniel I; Posada David; Subrahmanyan Lakshman; Cook Nancy R; Stanton Vincent P; Ridker Paul M
Pharmacogenetic study of statin therapy and cholesterol reduction.
JAMA : the journal of the American Medical Association 2004;291(23):2821-7.
-
2004: Ridker Paul M; Wilson Peter W F; Grundy Scott M
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
Circulation 2004;109(23):2818-25.
-
2004: Willerson James T; Ridker Paul M
Inflammation as a cardiovascular risk factor.
Circulation 2004;109(21 Suppl 1):II2-10.
-
2004: Smith Sidney C; Milani Richard V; Arnett Donna K; Crouse John R; McDermott Mary McGrae; Ridker Paul M; Rosenson Robert S; Taubert Kathryn A; Wilson Peter W F;
Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors.
Circulation 2004;109(21):2613-6.
-
2004: Albert Michelle A; Glynn Robert J; Buring Julie; Ridker Paul M
C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study).
The American journal of cardiology 2004;93(10):1238-42.
-
2004: Cook Nancy R; Zee Robert Y L; Ridker Paul M
Tree and spline based association analysis of gene-gene interaction models for ischemic stroke.
Statistics in medicine 2004;23(9):1439-53.
-
2004: Coffey Christopher S; Hebert Patricia R; Ritchie Marylyn D; Krumholz Harlan M; Gaziano J Michael; Ridker Paul M; Brown Nancy J; Vaughan Douglas E; Moore Jason H
An application of conditional logistic regression and multifactor dimensionality reduction for detecting gene-gene interactions on risk of myocardial infarction: the importance of model validation.
BMC bioinformatics 2004;5():49.
-
2004: Blake Gavin J; Pradhan Aruna D; Manson JoAnn E; Williams G Rhys; Buring Julie; Ridker Paul M; Glynn Robert J
Hemoglobin A1c level and future cardiovascular events among women.
Archives of internal medicine 2004;164(7):757-61.
-
2004: Ridker Paul M; Cook Nancy
Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores.
Circulation 2004;109(16):1955-9.
-
2004: Mason Peter J; Manson JoAnn E; Sesso Howard D; Albert Christine M; Chown Marilyn J; Cook Nancy R; Greenland Philip; Ridker Paul M; Glynn Robert J
Blood pressure and risk of secondary cardiovascular events in women: the Women's Antioxidant Cardiovascular Study (WACS).
Circulation 2004;109(13):1623-9.
-
2004: Humphries Steve E; Ridker Paul M; Talmud Philippa J
Genetic testing for cardiovascular disease susceptibility: a useful clinical management tool or possible misinformation?
Arteriosclerosis, thrombosis, and vascular biology 2004;24(4):628-36.
-
2004: Amowitz Lynn L; Ridker Paul M; Rifai Nadir; Loughrey Clodagh M; Komaroff Anthony L
High prevalence of metabolic syndrome among young women with nonfatal myocardial infarction.
Journal of women's health (2002) 2004;13(2):165-75; discussion 175.
-
2004: Libby Peter; Ridker Paul M
Inflammation and atherosclerosis: role of C-reactive protein in risk assessment.
The American journal of medicine 2004;116 Suppl 6A():9S-16S.
-
2004: Narins Craig R; Zareba Wojciech; Moss Arthur J; Marder Victor J; Ridker Paul M; Krone Ronald J; Lichstein Edgar
Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction.
Archives of internal medicine 2004;164(4):440-6.
-
2004: Meier-Ewert Hans K; Ridker Paul M; Rifai Nader; Regan Meredith M; Price Nick J; Dinges David F; Mullington Janet M
Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.
Journal of the American College of Cardiology 2004;43(4):678-83.
-
2004: Johnson B Delia; Kip Kevin E; Marroquin Oscar C; Ridker Paul M; Kelsey Sheryl F; Shaw Leslee J; Pepine Carl J; Sharaf Barry; Bairey Merz C Noel; Sopko George; Olson Marian B; Reis Steven E;
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Circulation 2004;109(6):726-32.
-
2004: Zee Robert Y L; Ridker Paul M; Cook Nancy R
Prospective evaluation of the alcohol dehydrogenase gamma1/gamma2 gene polymorphism and risk of stroke.
Stroke; a journal of cerebral circulation 2004;35(2):e39-42.
-
2004: Zee Robert Y L; Cook Nancy R; Cheng Suzanne; Reynolds Rebecca; Erlich Henry A; Lindpaintner Klaus; Ridker Paul M
Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
Human molecular genetics 2004;13(4):389-96.
-
2004: Albert Michelle A; Glynn Robert J; Ridker Paul M
Effect of physical activity on serum C-reactive protein.
The American journal of cardiology 2004;93(2):221-5.
-
2004: Ridker Paul M
Inflammation in atherothrombosis: how to use high-sensitivity C-reactive protein (hsCRP) in clinical practice.
The American heart hospital journal 2004;2(4 Suppl 1):4-9.
-
2004: Albert Michelle A; Ridker Paul M
Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis.
Reviews in cardiovascular medicine 2004;5 Suppl 3():S22-7.
-
2003: Sesso Howard D; Buring Julie E; Rifai Nader; Blake Gavin J; Gaziano J Michael; Ridker Paul M
C-reactive protein and the risk of developing hypertension.
JAMA : the journal of the American Medical Association 2003;290(22):2945-51.
-
2003: Corsetti James P; Zareba Wojciech; Moss Arthur J; Ridker Paul M; Marder Victor J; Rainwater David L; Sparks Charles E
Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients.
Atherosclerosis 2003;171(2):351-8.
-
2003: Blake Gavin J; Rifai Nader; Buring Julie E; Ridker Paul M
Blood pressure, C-reactive protein, and risk of future cardiovascular events.
Circulation 2003;108(24):2993-9.
-
2003: Ridker Paul M; Goldhaber Samuel Z; Glynn Robert J
Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;349(22):2164-7; author reply 2164-7.
-
2003: Ridker Paul M;
Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Circulation 2003;108(19):2292-7.
-
2003: Rexrode Kathryn M; Pradhan Aruna; Manson Joann E; Buring Julie E; Ridker Paul M
Relationship of total and abdominal adiposity with CRP and IL-6 in women.
Annals of epidemiology 2003;13(10):674-82.
-
2003: Torres José L; Ridker Paul M
Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events.
Current opinion in cardiology 2003;18(6):471-8.
-
2003: Blake Gavin J; Ridker Paul M
C-reactive protein: a surrogate risk marker or mediator of atherothrombosis?
American journal of physiology. Regulatory, integrative and comparative physiology 2003;285(5):R1250-2.
-
2003: Blake Gavin J; Albert Michelle A; Rifai Nader; Ridker Paul M
Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial.
European heart journal 2003;24(20):1843-7.
-
2003: Rexrode Kathryn M; Manson JoAnn E; Lee I-Min; Ridker Paul M; Sluss Patrick M; Cook Nancy R; Buring Julie E
Sex hormone levels and risk of cardiovascular events in postmenopausal women.
Circulation 2003;108(14):1688-93.
-
2003: Ridker Paul M
Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke.
Circulation 2003;108(12):e81-5.
-
2003: Engler Marguerite M; Engler Mary B; Malloy Mary J; Chiu Elisa Y; Schloetter Monique C; Paul Steven M; Stuehlinger Markus; Lin Ken Y; Cooke John P; Morrow Jason D; Ridker Paul M; Rifai Nader; Miller Elizabeth; Witztum Joseph L; Mietus-Snyder Michele
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.
Circulation 2003;108(9):1059-63.
-
2003: Ridker Paul M; Bassuk Shari S; Toth Peter P
C-reactive protein and risk of cardiovascular disease: evidence and clinical application.
Current atherosclerosis reports 2003;5(5):341-9.
-
2003: Ridker Paul M; Morrow David A
C-reactive protein, inflammation, and coronary risk.
Cardiology clinics 2003;21(3):315-25.
-
2003: Ridker Paul M
High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention.
The American journal of cardiology 2003;92(4B):17K-22K.
-
2003: Ford Earl S; Giles Wayne H; Myers Gary L; Rifai Nader; Ridker Paul M; Mannino David M
C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000.
Clinical chemistry 2003;49(8):1353-7.
-
2003: McDermott Mary M; Green David; Greenland Philip; Liu Kiang; Criqui Michael H; Chan Cheeling; Guralnik Jack M; Pearce William H; Ridker Paul M; Taylor Lloyd; Rifai Nader; Schneider Joseph R
Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index.
The American journal of cardiology 2003;92(2):194-9.
-
2003: Albert Michelle A; Glynn Robert J; Ridker Paul M
Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
Circulation 2003;108(2):161-5.
-
2003: McDermott Mary McGrae; Greenland Philip; Green David; Guralnik Jack M; Criqui Michael H; Liu Kiang; Chan Cheeling; Pearce William H; Taylor Lloyd; Ridker Paul M; Schneider Joseph R; Martin Gary; Rifai Nader; Quann Maureen; Fornage Myriam
D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease.
Circulation 2003;107(25):3191-8.
-
2003: Harb Tareq S; Zareba Wojciech; Moss Arthur J; Ridker Paul M; Rifai Nader; Marder Victor J; Miller-Watelet Luc;
Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients.
The American journal of cardiology 2003;91(9):1120-3.
-
2003: Ridker Paul M; Cook Nancy R; Cheng Suzanne; Erlich Henry A; Lindpaintner Klaus; Plutzky Jorge; Zee Robert Y L
Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(5):859-63.
-
2003: Blake Gavin J; Ridker Paul M; Kuntz Karen M
Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.
The American journal of medicine 2003;114(6):485-94.
-
2003: Pradhan Aruna D; Manson JoAnn E; Meigs James B; Rifai Nader; Buring Julie E; Liu Simin; Ridker Paul M
Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women.
The American journal of medicine 2003;114(6):438-44.
-
2003: Ridker Paul M
Connecting the role of C-reactive protein and statins in cardiovascular disease.
Clinical cardiology 2003;26(4 Suppl 3):III39-44.
-
2003: Pradhan Aruna D; Cook Nancy R; Buring Julie E; Manson JoAnn E; Ridker Paul M
C-reactive protein is independently associated with fasting insulin in nondiabetic women.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(4):650-5.
-
2003: Rifai Nader; Ridker Paul M
Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation.
Clinical chemistry 2003;49(4):666-9.
-
2003: Ridker Paul M; Goldhaber Samuel Z; Danielson Ellie; Rosenberg Yves; Eby Charles S; Deitcher Steven R; Cushman Mary; Moll Stephan; Kessler Craig M; Elliott C Gregory; Paulson Rolf; Wong Turnly; Bauer Kenneth A; Schwartz Bruce A; Miletich Joseph P; Bounameaux Henri; Glynn Robert J;
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
The New England journal of medicine 2003;348(15):1425-34.
-
2003: Blake Gavin J; Ridker Paul M
C-reactive protein and other inflammatory risk markers in acute coronary syndromes.
Journal of the American College of Cardiology 2003;41(4 Suppl S):37S-42S.
-
2003: McDermott Mary McGrae; Guralnik Jack M; Greenland Philip; Pearce William H; Criqui Michael H; Liu Kiang; Taylor Lloyd; Chan Cheeling; Sharma Leena; Schneider Joseph R; Ridker Paul M; Green David; Quann Maureen
Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease.
Circulation 2003;107(5):757-61.
-
2003: Liu Simin; Ma Jing; Ridker Paul M; Breslow Jan L; Stampfer Meir J
A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men.
Atherosclerosis 2003;166(2):323-9.
-
2003: Albert Michelle A; Glynn Robert J; Ridker Paul M
Alcohol consumption and plasma concentration of C-reactive protein.
Circulation 2003;107(3):443-7.
-
2003: Ridker Paul M; Buring Julie E; Cook Nancy R; Rifai Nader
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women.
Circulation 2003;107(3):391-7.
-
2003: Ridker Paul M
Clinical application of C-reactive protein for cardiovascular disease detection and prevention.
Circulation 2003;107(3):363-9.
-
2003: Blake Gavin J; Ostfeld Robert J; Yucel E Kent; Varo Nerea; Schönbeck Uwe; Blake Michael A; Gerhard Marie; Ridker Paul M; Libby Peter; Lee Richard T
Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(1):e11-4.
-
2003: Torres José L; Ridker Paul M
High sensitivity C-reactive protein in clinical practice.
The American heart hospital journal 2003;1(3):207-11.
-
2002: Ridker Paul M; Rifai Nader; Rose Lynda; Buring Julie E; Cook Nancy R
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.
The New England journal of medicine 2002;347(20):1557-65.
-
2002: Bermudez Edmund A; Rifai Nader; Buring Julie; Manson JoAnn E; Ridker Paul M
Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(10):1668-73.
-
2002: Blake Gavin J; Ridker Paul M
C-reactive protein, subclinical atherosclerosis, and risk of cardiovascular events.
Arteriosclerosis, thrombosis, and vascular biology 2002;22(10):1512-3.
-
2002: Blake Gavin J; Otvos James D; Rifai Nader; Ridker Paul M
Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women.
Circulation 2002;106(15):1930-7.
-
2002: Pai Jennifer K; Curhan Gary C; Cannuscio Carolyn C; Rifai Nader; Ridker Paul M; Rimm Eric B
Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection.
Clinical chemistry 2002;48(10):1781-4.
-
2002: Blann Andrew D; Ridker Paul M; Lip Gregory Y H
Inflammation, cell adhesion molecules, and stroke: tools in pathophysiology and epidemiology?
Stroke; a journal of cerebral circulation 2002;33(9):2141-3.
-
2002: Pradhan Aruna D; Manson JoAnn E; Rossouw Jacques E; Siscovick David S; Mouton Charles P; Rifai Nader; Wallace Robert B; Jackson Rebecca D; Pettinger Mary B; Ridker Paul M
Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
JAMA : the journal of the American Medical Association 2002;288(8):980-7.
-
2002: Pradhan Aruna D; Rifai Nader; Ridker Paul M
Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men.
Circulation 2002;106(7):820-5.
-
2002: Rifai Nader; Ridker Paul M
Inflammatory markers and coronary heart disease.
Current opinion in lipidology 2002;13(4):383-9.
-
2002: Blake Gavin J; Ridker Paul M; Kuntz Karen M
Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels.
Journal of the American College of Cardiology 2002;40(1):49-55.
-
2002: Brown David A; Breit Samuel N; Buring Julie; Fairlie W Douglas; Bauskin Asne R; Liu Tao; Ridker Paul M
Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study.
Lancet 2002;359(9324):2159-63.
-
2002: Albert Christine M; Ma Jing; Rifai Nader; Stampfer Meir J; Ridker Paul M
Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death.
Circulation 2002;105(22):2595-9.
-
2002: Ridker Paul M
Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum.
Circulation 2002;105(22):2583-5.
-
2002: Kinlay Scott; Timms Tracy; Clark Maureen; Karam Carolina; Bilodeau Tim; Ridker Paul M; Rifai Nader; Carlson William; Lloyd-Jones Donald M; Johnstone Michael; Rubenstein Joel; Alexander Sidney; Orav John; Stone Peter H;
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
The American journal of cardiology 2002;89(10):1205-7.
-
2002: Siegel Arthur J; Mendelson Jack H; Sholar Michelle B; McDonald Jane C; Lewandrowski Kent B; Lewandrowski Elizabeth L; Lipinska Izabella; Ridker Paul M; Tofler Geoffrey H
Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen.
The American journal of cardiology 2002;89(9):1133-5.
-
2002: Bermudez Edmund A; Rifai Nader; Buring Julie E; Manson JoAnn E; Ridker Paul M
Relation between markers of systemic vascular inflammation and smoking in women.
The American journal of cardiology 2002;89(9):1117-9.
-
2002: Zee Robert Y L; Ridker Paul M
Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis.
Atherosclerosis 2002;162(1):217-9.
-
2002: Zee Robert Y L; Bates David; Ridker Paul M
A prospective evaluation of the heat shock protein 70 gene polymorphisms and the risk of stroke.
Thrombosis and haemostasis 2002;87(4):622-5.
-
2002: Ridker Paul M; Shih Jessie; Cook Thomas J; Clearfield Michael; Downs John R; Pradhan Aruna D; Weis Stephan E; Gotto Antonio M;
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.
Circulation 2002;105(15):1776-9.
-
2002: Albert Christine M; Campos Hannia; Stampfer Meir J; Ridker Paul M; Manson JoAnn E; Willett Walter C; Ma Jing
Blood levels of long-chain n-3 fatty acids and the risk of sudden death.
The New England journal of medicine 2002;346(15):1113-8.
-
2002: Zee Robert Y L; Bates David; Ridker Paul M
A prospective evaluation of the CD14 and CD18 gene polymorphisms and risk of stroke.
Stroke; a journal of cerebral circulation 2002;33(4):892-5.
-
2002: Rifai Nader; Buring Julie E; Lee I-Min; Manson JoAnn E; Ridker Paul M
Is C-reactive protein specific for vascular disease in women?
Annals of internal medicine 2002;136(7):529-33.
-
2002: Liu Simin; Schmitz Christian; Stampfer Meir J; Sacks Frank; Hennekens Charles H; Lindpaintner Klaus; Ridker Paul M;
A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.
Atherosclerosis 2002;161(2):469-74.
-
2002: Libby Peter; Ridker Paul M; Maseri Attilio
Inflammation and atherosclerosis.
Circulation 2002;105(9):1135-43.
-
2002: Liu Simin; Manson JoAnn E; Buring Julie E; Stampfer Meir J; Willett Walter C; Ridker Paul M
Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women.
The American journal of clinical nutrition 2002;75(3):492-8.
-
2002: Eidelman Rachel S; Lamas Gervasio A; Hennekens Charles H; Ridker Paul M
Aspirin, postmenopausal hormones, and C-reactive protein.
Archives of internal medicine 2002;162(4):480-1.
-
2002: Harb Tareq S; Zareba Wojciech; Moss Arthur J; Ridker Paul M; Marder Victor J; Rifai Nader; Miller Watelet Luc F; Arora Rohit; Brown Mary W; Case Robert B; Dwyer Edward M; Gillespie John A; Goldstein Robert E; Greenberg Henry; Hochman Judith; Krone Ronald J; Liang Chang Seng; Lichstein Edgar; Little William; Marcus Frank I; Oakes David; Sparks Charles E; VanVoorhees Lucy;
Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction.
The American journal of cardiology 2002;89(2):216-21.
-
2002: Ridker Paul M
On evolutionary biology, inflammation, infection, and the causes of atherosclerosis.
Circulation 2002;105(1):2-4.
-
2002: Ridker Paul M
Inherited risk factors for venous thromboembolism: implications for clinical practice.
Clinical cornerstone 2002;4(6):18-30.
-
2002: Bermudez Edmund A; Ridker Paul M
C-reactive protein, statins, and the primary prevention of atherosclerotic cardiovascular disease.
Preventive cardiology 2002;5(1):42-6.
-
2001: Zee R Y; Lunze K; Lindpaintner K; Ridker P M
A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction.
Thrombosis and haemostasis 2001;86(5):1141-3.
-
2001: Blake G J; Ridker P M
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application.
Italian heart journal : official journal of the Italian Federation of Cardiology 2001;2(11):796-800.
-
2001: Schönbeck U; Varo N; Libby P; Buring J; Ridker P M
Soluble CD40L and cardiovascular risk in women.
Circulation 2001;104(19):2266-8.
-
2001: Blake G J; Dada N; Fox J C; Manson J E; Ridker P M
A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
Journal of the American College of Cardiology 2001;38(5):1302-6.
-
2001: Siegel A J; Stec J J; Lipinska I; Van Cott E M; Lewandrowski K B; Ridker P M; Tofler G H
Effect of marathon running on inflammatory and hemostatic markers.
The American journal of cardiology 2001;88(8):918-20, A9.
-
2001: Ridker P M
Role of inflammatory biomarkers in prediction of coronary heart disease.
Lancet 2001;358(9286):946-8.
-
2001: Chae C U; Lee R T; Rifai N; Ridker P M
Blood pressure and inflammation in apparently healthy men.
Hypertension 2001;38(3):399-403.
-
2001: Ridker P M; Danesh J; Youngman L; Collins R; Stampfer M J; Peto R; Hennekens C H
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.
Annals of internal medicine 2001;135(3):184-8.
-
2001: Albert M A; Danielson E; Rifai N; Ridker P M;
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
JAMA : the journal of the American Medical Association 2001;286(1):64-70.
-
2001: Ridker P M; Rifai N; Clearfield M; Downs J R; Weis S E; Miles J S; Gotto A M;
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.
The New England journal of medicine 2001;344(26):1959-65.
-
2001: Albert M A; Staggers J; Chew P; Ridker P M;
The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
American heart journal 2001;141(6):893-8.
-
2001: Ridker P M; Stampfer M J; Rifai N
Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.
JAMA : the journal of the American Medical Association 2001;285(19):2481-5.
-
2001: Ridker P M
High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
Circulation 2001;103(13):1813-8.
-
2001: Meier-Ewert H K; Ridker P M; Rifai N; Price N; Dinges D F; Mullington J M
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects.
Clinical chemistry 2001;47(3):426-30.
-
2001: Rifai N; Ridker P M
High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.
Clinical chemistry 2001;47(3):403-11.
-
2001: Ridker P M; Rifai N; Lowenthal S P
Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia.
Circulation 2001;103(9):1191-3.
-
2001: Zee R Y; Lindpaintner K; Struk B; Hennekens C H; Ridker P M
A prospective evaluation of the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction.
Atherosclerosis 2001;154(3):699-702.
-
2001: Howell T H; Ridker P M; Ajani U A; Hennekens C H; Christen W G
Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians.
Journal of the American College of Cardiology 2001;37(2):445-50.
-
2001: Hines L M; Stampfer M J; Ma J; Gaziano J M; Ridker P M; Hankinson S E; Sacks F; Rimm E B; Hunter D J
Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction.
The New England journal of medicine 2001;344(8):549-55.
-
2001: Ridker P M; Buring J E; Rifai N
Soluble P-selectin and the risk of future cardiovascular events.
Circulation 2001;103(4):491-5.
-
2001: Rifai N; Ridker P M
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening.
Clinical chemistry 2001;47(1):28-30.
-
2001: Albert M A; Rifai N; Ridker P M
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis.
Vascular medicine (London, England) 2001;6(3):145-9.
-
2000: de Lemos J A; Hennekens C H; Ridker P M
Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.
Journal of the American College of Cardiology 2000;36(2):423-6.
-
2000: Ridker P M
Are statins anti-inflammatory? Issues in the design and conduct of the pravastatin inflammation C-reactive protein evaluation.
Current cardiology reports 2000;2(4):269-73.
-
2000: Redberg R F; Rifai N; Gee L; Ridker P M
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening.
Journal of the American College of Cardiology 2000;36(1):39-43.
-
2000: Christen W G; Ridker P M
Blood levels of homocysteine and atherosclerotic vascular disease.
Current atherosclerosis reports 2000;2(3):194-9.
-
2000: Ridker P M; Rifai N; Stampfer M J; Hennekens C H
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.
Circulation 2000;101(15):1767-72.
-
2000: Ridker P M; Hennekens C H; Buring J E; Rifai N
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
The New England journal of medicine 2000;342(12):836-43.
-
2000: Ridker P M
Inherited risk factors for venous thromboembolism: implications for clinical practice.
Clinical cornerstone 2000;2(4):1-14.
-
2000: Ridker P M
Novel risk factors and markers for coronary disease.
Advances in internal medicine 2000;45():391-418.
-
1999: Rifai N; Tracy R P; Ridker P M
Clinical efficacy of an automated high-sensitivity C-reactive protein assay.
Clinical chemistry 1999;45(12):2136-41.
-
1999: Shi G P; Sukhova G K; Grubb A; Ducharme A; Rhode L H; Lee R T; Ridker P M; Libby P; Chapman H A
Cystatin C deficiency in human atherosclerosis and aortic aneurysms.
The Journal of clinical investigation 1999;104(9):1191-7.
-
1999: Rubattu S; Ridker P; Stampfer M J; Volpe M; Hennekens C H; Lindpaintner K
The gene encoding atrial natriuretic peptide and the risk of human stroke.
Circulation 1999;100(16):1722-6.
-
1999: Ridker P M; Hennekens C H; Buring J E; Kundsin R; Shih J
Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women.
Annals of internal medicine 1999;131(8):573-7.
-
1999: Ridker P M; Antman E M
Pathogenesis and pathology of coronary heart disease syndromes.
Journal of thrombosis and thrombolysis 1999;8(3):167-89.
-
1999: Siegel A J; Sholar M B; Mendelson J H; Lukas S E; Kaufman M J; Renshaw P F; McDonald J C; Lewandrowski K B; Apple F S; Stec J J; Lipinska I; Tofler G H; Ridker P M
Cocaine-induced erythrocytosis and increase in von Willebrand factor: evidence for drug-related blood doping and prothrombotic effects.
Archives of internal medicine 1999;159(16):1925-9.
-
1999: Ridker P M; Hennekens C H; Rifai N; Buring J E; Manson J E
Hormone replacement therapy and increased plasma concentration of C-reactive protein.
Circulation 1999;100(7):713-6.
-
1999: Albert M A; Ridker P M
The role of C-reactive protein in cardiovascular disease risk.
Current cardiology reports 1999;1(2):99-104.
-
1999: Ridker P M; Rifai N; Pfeffer M A; Sacks F; Braunwald E
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators.
Circulation 1999;100(3):230-5.
-
1999: Rohde L E; Arroyo L H; Rifai N; Creager M A; Libby P; Ridker P M; Lee R T
Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1695-9.
-
1999: Rohde L E; Hennekens C H; Ridker P M
Cross-sectional study of soluble intercellular adhesion molecule-1 and cardiovascular risk factors in apparently healthy men.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(7):1595-9.
-
1999: Ridker P M
Evaluating novel cardiovascular risk factors: can we better predict heart attacks?
Annals of internal medicine 1999;130(11):933-7.
-
1999: Ridker P M; Hennekens C H; Miletich J P
G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.
Circulation 1999;99(8):999-1004.
-
1999: Amowitz L L; Komaroff A L; Miletich J P; Ridker P M
Factor V Leiden is not a risk factor for myocardial infarction among young women.
Blood 1999;93(4):1432-3.
-
1999: Ridker P M; Stampfer M J
Assessment of genetic markers for coronary thrombosis: promise and precaution.
Lancet 1999;353(9154):687-8.
-
1999: Zee R Y; Ridker P M; Stampfer M J; Hennekens C H; Lindpaintner K
Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke.
Circulation 1999;99(3):340-3.
-
1998: Ridker P M; Hennekens C H; Stampfer M J; Wang F
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke.
Circulation 1998;98(25):2796-9.
-
1998: Rohde L E; Lee R T; Rivero J; Jamacochian M; Arroyo L H; Briggs W; Rifai N; Libby P; Creager M A; Ridker P M
Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(11):1765-70.
-
1998: Ridker P M; Rifai N; Pfeffer M A; Sacks F M; Moye L A; Goldman S; Flaker G C; Braunwald E
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.
Circulation 1998;98(9):839-44.
-
1998: Ridker P M; Miletich J P; Buring J E; Ariyo A A; Price D T; Manson J E; Hill J A
Factor V Leiden mutation as a risk factor for recurrent pregnancy loss.
Annals of internal medicine 1998;128(12 Pt 1):1000-3.
-
1998: Ridker P M; Glynn R J; Hennekens C H
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction.
Circulation 1998;97(20):2007-11.
-
1998: Ridker P M; Cushman M; Stampfer M J; Tracy R P; Hennekens C H
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
Circulation 1998;97(5):425-8.
-
1998: Ridker P M; Hennekens C H; Roitman-Johnson B; Stampfer M J; Allen J
Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.
Lancet 1998;351(9096):88-92.
-
1998: Ridker P M
Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial.
Vascular medicine (London, England) 1998;3(1):67-73.
-
1997: Price D T; Ridker P M
Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Annals of internal medicine 1997;127(10):895-903.
-
1997: McConnell M V; Vavouranakis I; Wu L L; Vaughan D E; Ridker P M
Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk.
The American journal of cardiology 1997;80(9):1226-8.
-
1997: Ridker P M; Baker M T; Hennekens C H; Stampfer M J; Vaughan D E
Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1687-90.
-
1997: Vaughan D E; Rouleau J L; Ridker P M; Arnold J M; Menapace F J; Pfeffer M A
Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.
Circulation 1997;96(2):442-7.
-
1997: Chae C U; Ridker P M; Manson J E
Postmenopausal hormone replacement therapy and cardiovascular disease.
Thrombosis and haemostasis 1997;78(1):770-80.
-
1997: Ridker P M
Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasis.
Thrombosis and haemostasis 1997;78(1):53-9.
-
1997: Pfeffer M A; Greaves S C; Arnold J M; Glynn R J; LaMotte F S; Lee R T; Menapace F J; Rapaport E; Ridker P M; Rouleau J L; Solomon S D; Hennekens C H
Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial.
Circulation 1997;95(12):2643-51.
-
1997: Ridker P M; Miletich J P; Hennekens C H; Buring J E
Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.
JAMA : the journal of the American Medical Association 1997;277(16):1305-7.
-
1997: Ridker P M; Hennekens C H; Selhub J; Miletich J P; Malinow M R; Stampfer M J
Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.
Circulation 1997;95(7):1777-82.
-
1997: Ridker P M; Glynn R J; Miletich J P; Goldhaber S Z; Stampfer M J; Hennekens C H
Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
Annals of internal medicine 1997;126(7):528-31.
-
1997: Ridker P M; Cushman M; Stampfer M J; Tracy R P; Hennekens C H
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
The New England journal of medicine 1997;336(14):973-9.
-
1997: O'Donnell C J; Ridker P M; Glynn R J; Berger K; Ajani U; Manson J E; Hennekens C H
Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians.
Circulation 1997;95(5):1132-7.
-
1997: Ridker P M; Hennekens C H; Schmitz C; Stampfer M J; Lindpaintner K
PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.
Lancet 1997;349(9049):385-8.
-
1997: Ridker P M; Hennekens C H; Lindpaintner K; Stampfer M J; Miletich J P
Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.
Circulation 1997;95(1):59-62.
-
1996: Stevenson W G; Ridker P M
Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
JAMA : the journal of the American Medical Association 1996;276(6):481-5.
-
1996: Hennekens C H; Buring J E; Manson J E; Stampfer M; Rosner B; Cook N R; Belanger C; LaMotte F; Gaziano J M; Ridker P M; Willett W; Peto R
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
The New England journal of medicine 1996;334(18):1145-9.
-
1995: Ridker P M; Miletich J P; Stampfer M J; Goldhaber S Z; Lindpaintner K; Hennekens C H
Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
Circulation 1995;92(10):2800-2.
-
1995: Hennekens C H; O'Donnell C J; Ridker P M
Current and future perspectives on antithrombotic therapy of acute myocardial infarction.
European heart journal 1995;16 Suppl D():2-9.
-
1995: Manson J E; Gaziano J M; Spelsberg A; Ridker P M; Cook N R; Buring J E; Willett W C; Hennekens C H
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group.
Annals of epidemiology 1995;5(4):261-9.
-
1995: O'Donnell C J; Ridker P M; Hebert P R; Hennekens C H
Antithrombotic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 1995;25(7 Suppl):23S-29S.
-
1995: Hennekens C H; O'Donnell C J; Ridker P M; Marder V J
Current issues concerning thrombolytic therapy for acute myocardial infarction.
Journal of the American College of Cardiology 1995;25(7 Suppl):18S-22S.
-
1995: Gaziano J M; Johnson E J; Russell R M; Manson J E; Stampfer M J; Ridker P M; Frei B; Hennekens C H; Krinsky N I
Discrimination in absorption or transport of beta-carotene isomers after oral supplementation with either all-trans- or 9-cis-beta-carotene.
The American journal of clinical nutrition 1995;61(6):1248-52.
-
1995: Ridker P M; Hennekens C H; Lindpaintner K; Stampfer M J; Eisenberg P R; Miletich J P
Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
The New England journal of medicine 1995;332(14):912-7.
-
1995: Ridker P M; Stampfer M J; Hennekens C H
Plasma concentration of lipoprotein(a) and the risk of future stroke.
JAMA : the journal of the American Medical Association 1995;273(16):1269-73.
-
1995: Gaziano J M; Hatta A; Flynn M; Johnson E J; Krinsky N I; Ridker P M; Hennekens C H; Frei B
Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation.
Atherosclerosis 1995;112(2):187-95.
-
1994: Ridker P M; Hennekens C H; Cerskus A; Stampfer M J
Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.
Circulation 1994;90(5):2236-40.
-
1994: Ridker P M; Hennekens C H
Lipoprotein(a) and risks of cardiovascular disease.
Annals of epidemiology 1994;4(5):360-2.
-
1994: Ridker P M; Vaughan D E; Stampfer M J; Glynn R J; Hennekens C H
Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.
JAMA : the journal of the American Medical Association 1994;272(12):929-33.
-
1994: Ridker P M; Hennekens C H; Stampfer M J; Manson J E; Vaughan D E
Prospective study of endogenous tissue plasminogen activator and risk of stroke.
Lancet 1994;343(8903):940-3.
-
1993: Solomon S D; Ridker P M; Antman E M
Ventricular arrhythmias in trials of thrombolytic therapy for acute myocardial infarction. A meta-analysis.
Circulation 1993;88(6):2575-81.
-
1993: Ridker P M; Hennekens C H; Stampfer M J
A prospective study of lipoprotein(a) and the risk of myocardial infarction.
JAMA : the journal of the American Medical Association 1993;270(18):2195-9.
-
1993: Hebert P R; Rich-Edwards J W; Manson J E; Ridker P M; Cook N R; O'Connor G T; Buring J E; Hennekens C H
Height and incidence of cardiovascular disease in male physicians.
Circulation 1993;88(4 Pt 1):1437-43.
-
1993: Solomon S D; Wolff S; Watkins H; Ridker P M; Come P; McKenna W J; Seidman C E; Lee R T
Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain gene.
Journal of the American College of Cardiology 1993;22(2):498-505.
-
1993: Ridker P M; Gaboury C L; Conlin P R; Seely E W; Williams G H; Vaughan D E
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
Circulation 1993;87(6):1969-73.
-
1993: Ridker P M; Hebert P R; Fuster V; Hennekens C H
Are both aspirin and heparin justified as adjuncts to thrombolytic therapy for acute myocardial infarction?
Lancet 1993;341(8860):1574-7.
-
1993: Ridker P M; Vaughan D E; Stampfer M J; Manson J E; Hennekens C H
Endogenous tissue-type plasminogen activator and risk of myocardial infarction.
Lancet 1993;341(8854):1165-8.
-
1992: Ridker P M; Manson J E; Goldhaber S Z; Hennekens C H; Buring J E
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarction.
The American journal of cardiology 1992;70(1):10-3.
-
1992: Ridker P M; Vaughan D E; Stampfer M J; Manson J E; Shen C; Newcomer L M; Goldhaber S Z; Hennekens C H
Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
Circulation 1992;85(5):1822-7.
-
1992: Manson J E; Tosteson H; Ridker P M; Satterfield S; Hebert P; O'Connor G T; Buring J E; Hennekens C H
The primary prevention of myocardial infarction.
The New England journal of medicine 1992;326(21):1406-16.
-
1991: Ridker P M; Manson J E; Buring J E; Goldhaber S Z; Hennekens C H
Clinical characteristics of nonfatal myocardial infarction among individuals on prophylactic low-dose aspirin therapy.
Circulation 1991;84(2):708-11.
-
1991: Ridker P M; Manson J E; Gaziano J M; Buring J E; Hennekens C H
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.
Annals of internal medicine 1991;114(10):835-9.
-
1990: Ridker P M; Manson J E; Buring J E; Muller J E; Hennekens C H
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.
Circulation 1990;82(3):897-902.
-
1989: Ridker P M; McDermott W V
Comfrey herb tea and hepatic veno-occlusive disease.
Lancet 1989;1(8639):657-8.
Sign-in to see more